Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 106 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C15H10BrFN2O |
Molar mass | 333.160 g·mol−1 |
3D model ( JSmol) | |
| |
|
Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, [1] but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug. [2] [3] [4] [5] [6] [7] [8]
It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.
An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one or "iso-flubromazepam", [9] may have been sold under the same name. [2]
In the UK, flubromazepam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs. [10]
Flubromazepam, clonazolam, and flubromazolam are Schedule I controlled substances under Virginia State Law. [11]
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 106 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C15H10BrFN2O |
Molar mass | 333.160 g·mol−1 |
3D model ( JSmol) | |
| |
|
Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, [1] but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug. [2] [3] [4] [5] [6] [7] [8]
It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.
An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one or "iso-flubromazepam", [9] may have been sold under the same name. [2]
In the UK, flubromazepam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs. [10]
Flubromazepam, clonazolam, and flubromazolam are Schedule I controlled substances under Virginia State Law. [11]